B7-independent inhibition of T cells by CTLA-4 - PubMed (original) (raw)

B7-independent inhibition of T cells by CTLA-4

Shunsuke Chikuma et al. J Immunol. 2005.

Abstract

CTLA-4 is an inhibitory molecule that regulates T cell expansion and differentiation. CTLA-4 binding to B7-1/B7-2 is believed to be crucial for its inhibitory signal both by competing for CD28 binding to the same ligands and aggregating CTLA-4 to deliver negative signals. In this study, we demonstrate that B7 binding is not essential for CTLA-4 activity. CTLA-4 knockout T cells are hyperresponsive compared with wild-type T cells in B7-free settings. Expression of a B7-nonbinding CTLA-4 mutant inhibited T cell proliferation, cytokine production, and TCR-mediated ERK activation in otherwise CTLA-4-deficient T cells. Finally, transgenic expression of the ligand-nonbinding CTLA-4 mutant delayed the lethal lymphoproliferation observed in CTLA-4-deficient mice. These results suggest that ligand binding is not essential for the CTLA-4 function and supports an essential role for CTLA-4 signaling during T cell activation.

PubMed Disclaimer

Similar articles

• Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
  Frauwirth KA, Alegre ML, Thompson CB. Frauwirth KA, et al. J Immunol. 2000 Mar 15;164(6):2987-93. doi: 10.4049/jimmunol.164.6.2987. J Immunol. 2000. PMID: 10706686
• B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
  Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR. Taylor PA, et al. J Immunol. 2004 Jan 1;172(1):34-9. doi: 10.4049/jimmunol.172.1.34. J Immunol. 2004. PMID: 14688306
• Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
  Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N. Ito T, et al. J Immunol. 2005 Jun 1;174(11):6648-56. doi: 10.4049/jimmunol.174.11.6648. J Immunol. 2005. PMID: 15905503
• CTLA-4 and T cell activation.
  Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. Oosterwegel MA, et al. Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8. Curr Opin Immunol. 1999. PMID: 10375557 Review.
• The complexities of T-cell co-stimulation: CD28 and beyond.
  Sperling AI, Bluestone JA. Sperling AI, et al. Immunol Rev. 1996 Oct;153:155-82. doi: 10.1111/j.1600-065x.1996.tb00924.x. Immunol Rev. 1996. PMID: 9010723 Review. No abstract available.

Cited by

• Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken.
  Falcon DM, Byrne KA, Sales MA, Erf GF. Falcon DM, et al. Front Immunol. 2024 Apr 24;15:1386727. doi: 10.3389/fimmu.2024.1386727. eCollection 2024. Front Immunol. 2024. PMID: 38720888 Free PMC article.
• Current understanding of CTLA-4: from mechanism to autoimmune diseases.
  Hossen MM, Ma Y, Yin Z, Xia Y, Du J, Huang JY, Huang JJ, Zou L, Ye Z, Huang Z. Hossen MM, et al. Front Immunol. 2023 Jul 11;14:1198365. doi: 10.3389/fimmu.2023.1198365. eCollection 2023. Front Immunol. 2023. PMID: 37497212 Free PMC article. Review.
• Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.
  Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S. Dutta S, et al. Biology (Basel). 2023 Jan 30;12(2):218. doi: 10.3390/biology12020218. Biology (Basel). 2023. PMID: 36829496 Free PMC article. Review.
• Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy.
  Kim GR, Choi JM. Kim GR, et al. Mol Cells. 2022 Aug 31;45(8):513-521. doi: 10.14348/molcells.2022.2056. Epub 2022 Jul 27. Mol Cells. 2022. PMID: 35950451 Free PMC article. Review.
• Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations.
  Balázs K, Kocsis ZS, Ágoston P, Jorgo K, Gesztesi L, Farkas G, Székely G, Takácsi-Nagy Z, Polgár C, Sáfrány G, Jurányi Z, Lumniczky K. Balázs K, et al. Cancers (Basel). 2022 Jun 22;14(13):3058. doi: 10.3390/cancers14133058. Cancers (Basel). 2022. PMID: 35804830 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal